Celularity Inc. Repayments of Short-term Debt
Celularity Inc. (CELU) reported Repayments of Short-term Debt of $121.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2026-04-30
- Celularity Inc. repayments of short-term debt for the quarter ending 2025-12-31 was $8.00K, a 80.00% decline year-over-year.
- Celularity Inc. repayments of short-term debt for the quarter ending 2024-12-31 was $40.00K.
- Celularity Inc. repayments of short-term debt for the quarter ending 2023-12-31 was $0.00.
- Celularity Inc. repayments of short-term debt for the quarter ending 2023-09-30 was $0.00.
- Celularity Inc. repayments of short-term debt for fiscal 2025 was $121.00K, a 17.12% decline from fiscal 2024.
- Celularity Inc. repayments of short-term debt for fiscal 2024 was $146.00K, a 99.13% decline from fiscal 2023.
- Celularity Inc. repayments of short-term debt for fiscal 2023 was $16.81M.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $121.00K 10-K · filed 2026-04-30 | ||
| 2025-09-30 | $113.00K 10-Q · filed 2025-11-14 | |||
| 2024-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $146.00K 10-K · filed 2026-04-30 | ||
| 2024-09-30 | $106.00K 10-Q · filed 2025-11-14 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $0.00 derived: sum of 2 quarters · filed 2024-07-30 | $15.19M derived: sum of 3 quarters · filed 2024-07-30 | $16.81M 10-K · filed 2024-07-30 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-03 | $15.19M derived: sum of 2 quarters · filed 2024-01-03 | $16.81M 10-Q · filed 2024-01-03 | |
| 2023-06-30 | $15.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $16.81M 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $1.62M 10-Q · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |